Center for Disease Dynamics, Economics & Policy

What Center for Disease Dynamics, Economics & Policy does

The Center for Disease Dynamics, Economics & Policy (CDDEP), now operating as One Health Trust (OHT), is a private non-profit global health research organization founded in 2010 and headquartered in Silver Spring, Maryland, with operations spanning Africa, Asia, North America, India, and Bangladesh. The organization produces interdisciplinary research integrating disease dynamics, health economics, and policy analysis, with core emphasis on antimicrobial resistance (AMR), communicable disease dynamics, vaccines, climate and food systems, noncommunicable diseases, gender equity, and pandemic preparedness. Its outputs are delivered through peer-reviewed publications (e.g., The Lancet, BMJ, Nature Reviews Microbiology), policy reports, infographics, podcasts, webinars, a weekly digest, and a Hindustan Times column ("Vital Signs"). Technical assets include synthetic population models constructed from U.S. census data for epidemic simulation, and pharmaceutical sales-data analyses covering 70+ countries used to track antibiotic consumption and resistance trends. Specialized initiatives include the Global Antibiotic Resistance Partnership (GARP), a WHO Collaborating Centre for Antimicrobial Resistance designation, the OxygenForIndia program, and the planned Nimai Valley headquarters. The organization also operates academic training capacity (PhD, study abroad, internship, and course programs). Revenue is generated through donations and grants from institutional donors, governments, and international organizations; primary end-users are governments and policymakers, academic and research institutions, and intergovernmental bodies such as WHO and FAO.

Name

Center for Disease Dynamics, Economics & Policy

Legal name

One Health Trust

Website

https://cddep.org

Company type

Private

Founded year

2010

Operating status

Operating

Headcount range

11–50 employees

Short description

One Health Trust (formerly CDDEP) is a global non-profit health research organization producing evidence-based policy analysis on antimicrobial resistance, infectious disease, vaccines, and climate-health, serving governments, academic institutions, and bodies such as WHO and FAO.

Ownership category

akta.pro rank

Product category

Global Health Research

NAICS

Scientific Research and Development Services (5417), Research and Development in the Physical, Engineering, and Life Sciences (54171), Health Care and Social Assistance (62)

SIC

Services-Health Services (8000), Services-Commercial Physical & Biological Research (8731), Services-Membership Organizations (8600)

akta.pro primary industry

Global Health Research, Evidence & Technical Assistance Organizations (HLAJAKAN)

akta.pro secondary industries

Multilateral Global Health Partnerships (UN/WHO-led Initiatives) (HLAJAOAA), Immunization & Vaccine Access Partnerships (Global Vaccine Alliances) (HLAJAOAF), One Health & Zoonotic Disease Partnerships (Human–Animal–Environment) (HLAJAOAJ)

Keywords

• Global health research
• Antimicrobial resistance policy
• Public health economics
• Disease dynamics analysis
• Health policy research

Headquarters

HQ city

Washington

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales

Revenue model

1. Donations and Grants: Non-profit research organization funded primarily through donations and grants from institutional donors, governments, and international organizations to support global health research.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels7 records

Core offering

The Center for Disease Dynamics, Economics & Policy (now operating as One Health Trust) is a non-profit research organization that conducts interdisciplinary global health research spanning antimicrobial resistance, communicable disease dynamics, vaccines, climate and health, gender equity, and noncommunicable diseases. Its deliverables include peer-reviewed publications, policy reports, infographics, and academic training programs (PhD, Study Abroad, Internship, and Courses). The organization also convenes the Global Antibiotic Resistance Partnership (GARP) network and operates a designated WHO Collaborating Centre for Antimicrobial Resistance.

Product overview

One Health Trust (formerly Center for Disease Dynamics, Economics & Policy) is a global health research organization that operates as a platform of interconnected research initiatives, educational programs, and knowledge-dissemination products. The core offerings include peer-reviewed research publications and policy reports on antimicrobial resistance, disease dynamics, and health systems; academic training programs (PhD, Study Abroad, Internship, and professional Courses); and media content products (Weekly Digest, Podcasts, Webinars, Blog, and Vital Signs column). The organization also runs specialized research initiatives including the Global Antibiotic Resistance Partnership (GARP), the WHO Collaborating Centre for Antimicrobial Resistance, OxygenForIndia, and the Nimai Valley headquarters project. These offerings collectively support the organization's mission of improving health equity and pandemic preparedness through research, training, and evidence-based policy advocacy.

Differentiator

Problem solved

Functional benefit

Brands

• Global Antibiotic Resistance Partnership (GARP): Working with local stakeholders to leverage vaccines in the fight to control antimicrobial resistance
• OxygenForIndia
• Vital Signs

Products and services

• PhD Program Doctoral training program in global health, public health, and related disciplines, designed for graduate students pursuing research careers.
• Study Abroad Program International study opportunities for students interested in global health research and practice.
• Internship Program Practical training opportunities for students and early-career professionals in global health research.
• Courses Educational courses in global health, epidemiology, and related topics offered to students and professionals.
• Reports Policy briefs, white papers, and analytical reports on global health challenges including AMR, pandemic preparedness, and health system strengthening, distributed to governments, WHO, FAO, and policymakers.
• Peer-Reviewed Articles Academic publications in peer-reviewed journals covering antimicrobial resistance, disease dynamics, vaccines, climate health impacts, and global health policy.
• Global Antibiotic Resistance Partnership (GARP) Network working with local stakeholders in low- and middle-income countries to develop evidence-based policies for antimicrobial resistance containment, including leveraging vaccines to control AMR.
• WHO Collaborating Centre for Antimicrobial Resistance WHO-designated collaborating centre focused on applying National Action Plans to control drug resistance in African countries and other regions.
• OxygenForIndia Initiative addressing medical oxygen access and availability in India, particularly during health emergencies.
• Weekly Digest Curated email summary of latest scientific literature in global health, delivered weekly to subscribers.

Quantifiable outcome

• Research found that raising taxes on bidis could save millions of years of healthy life and generate substantial economic gains
• +2 more outcomes

Segments3 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

Four partnerships are on record, tiered core.

• World Health Organization (WHO)coreStrategic or Co-development PartnerCDDEP is designated as a WHO Collaborating Centre for Antimicrobial Resistance. Works on applying National Action Plans to control drug resistance in diverse African countries and supports WHO's global AMR monitoring initiatives.
• Food and Agriculture Organization of the United Nations (FAO)coreStrategic or Co-development PartnerFAO collaborated with OHT's Dr. Ramanan Laxminarayan on a report exploring the economic impacts of phasing out antimicrobial growth promoters and long-term consequences of rising AMR in livestock production.
• EAT-Lancet CommissioncoreStrategic or Co-development PartnerOHT's Dr. Ramanan Laxminarayan participates in the EAT-Lancet Commission which proposes global food system transformation to improve human and planetary health.
• Global Antibiotic Resistance Partnership (GARP)coreStrategic or Co-development PartnerGARP works with local stakeholders to leverage vaccines in the fight to control antimicrobial resistance, operating through national networks in multiple countries.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• Center for Global Development: Independent policy think tank producing research on global health, development economics, and policy reform. Most directly comparable to OHT given shared focus on combining economic analysis with health policy advice for governments and multilaterals.
• CDC Foundation: Nonprofit supporting the U.S. Centers for Disease Control and Prevention's global health mission. Comparable as a public-health-oriented nonprofit generating evidence and supporting government policy responses.
• Clinton Health Access Initiative (CHAI): Global health nonprofit operating across more than 30 countries to improve access to medicines, diagnostics, and vaccines. Closely comparable as a research-to-implementation nonprofit partnering with governments and multilaterals on infectious disease policy.
• Resolve to Save Lives: Nonprofit focused on cardiovascular disease and epidemic prevention in low- and middle-income countries, working with governments on policy implementation. Comparable in operating model and direct engagement with national health authorities.
• Institute for Health Metrics and Evaluation (IHME): Global health research institute producing comparable population-level health data and country-level disease burden estimates. Closely comparable in mission and academic-policy hybrid model, though larger and broader in disease scope.
• PATH: Global health nonprofit advancing health equity through innovation in vaccines, drugs, and diagnostics. Comparable as a research-and-implementation organization working on infectious disease and AMR-related policy across LMICs.
• Georgetown Center for Global Health Science and Security: Academic policy center conducting research on global health security, pandemic preparedness, and disease dynamics. Comparable in combining epidemiology with policy engagement and country-level capacity building.
• ReAct – Action on Antibiotic Resistance: International network dedicated to addressing antibiotic resistance through research, advocacy, and policy support. Direct peer in the AMR-focused global health space, with similar country-level engagement.

Broad incumbents

• Wellcome Trust: Major global health philanthropy and research funder with substantial AMR programs. Comparable as a leading institution in AMR research and policy, though operates as a funder rather than implementer.
• Bill & Melinda Gates Foundation: Largest global health funder with major investments in vaccines, infectious disease, and AMR. Comparable as an agenda-setter in OHT's core domains, though operating at vastly greater scale and as a funder rather than implementer.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/cddep
• Facebookfacebook.com/cddep

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Center for Disease Dynamics, Economics & Policy